Parkinson's disease medication state and severity assessment based on coordination during walking.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 25 05 2020
accepted: 18 12 2020
entrez: 17 2 2021
pubmed: 18 2 2021
medline: 29 7 2021
Statut: epublish

Résumé

Walking is a complex motor function requiring coordination of all body parts. Parkinson's disease (PD) motor signs such as rigidity, bradykinesia, and impaired balance affect movements including walking. Here, we propose a computational method to objectively assess the effects of Parkinson's disease pathology on coordination between trunk, shoulder and limbs during the gait cycle to assess medication state and disease severity. Movements during a scripted walking task were extracted from wearable devices placed at six different body locations in participants with PD and healthy participants. Three-axis accelerometer data from each device was synchronized at the beginning of either left or right steps. Canonical templates of movements were then extracted from each body location. Movements projected on those templates created a reduced dimensionality space, where complex movements are represented as discrete values. These projections enabled us to relate the body coordination in people with PD to disease severity. Our results show that the velocity profile of the right wrist and right foot during right steps correlated with the participant's total score on the gold standard Unified Parkinson's Disease Rating Scale (UPRDS) with an r2 up to 0.46. Left-right symmetry of feet, trunk and wrists also correlated with the total UPDRS score with an r2 up to 0.3. In addition, we demonstrate that binary dopamine replacement therapy medication states (self-reported 'ON' or 'OFF') can be discriminated in PD participants. In conclusion, we showed that during walking, the movement of body parts individually and in coordination with one another changes in predictable ways that vary with disease severity and medication state.

Identifiants

pubmed: 33596202
doi: 10.1371/journal.pone.0244842
pii: PONE-D-20-15516
pmc: PMC7888646
doi:

Substances chimiques

Dopamine Agents 0
Levodopa 46627O600J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244842

Déclaration de conflit d'intérêts

C. Agurto, S. Heisig, A. Abrami, V. Caggiano, disclose that their employer, IBM Research, is the research branch of IBM Corporation. B.K. Ho is employed by the Department of Neurology, Tufts University School of Medicine and Tufts Medical Center. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Expert Rev Med Devices. 2016 May;13(5):455-62
pubmed: 26872510
IEEE J Biomed Health Inform. 2016 May;20(3):838-847
pubmed: 25850097
Gait Posture. 2012 Mar;35(3):373-7
pubmed: 22098825
IEEE J Biomed Health Inform. 2015 Nov;19(6):1777-93
pubmed: 26316236
Neurorehabil Neural Repair. 2011 Nov-Dec;25(9):810-8
pubmed: 21989633
Neurosci Res. 2004 Oct;50(2):137-51
pubmed: 15380321
Clin Biomech (Bristol, Avon). 2014 Dec;29(10):1089-94
pubmed: 25467810
Mov Disord. 2016 Sep;31(9):1293-313
pubmed: 27452964
Nature. 2018 Jan 25;553(7689):455-460
pubmed: 29342142
Elife. 2019 Jan 21;8:
pubmed: 30663578
J Parkinsons Dis. 2015;5(1):141-50
pubmed: 25502948
Lancet Neurol. 2006 Sep;5(9):796-802
pubmed: 16914408
Gait Posture. 2010 Feb;31(2):256-60
pubmed: 19945285
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
J Neurol. 2014 Dec;261(12):2401-10
pubmed: 25249296
Sensors (Basel). 2014 Mar 07;14(3):4618-33
pubmed: 24608005
J Mot Behav. 2001 Mar;33(1):86-102
pubmed: 11303522
Gait Posture. 2012 May;36(1):120-6
pubmed: 22390962
J Phys Ther Sci. 2018 May;30(5):658-662
pubmed: 29765175
Lancet Neurol. 2019 Jul;18(7):697-708
pubmed: 30975519
Front Neuroanat. 2016 Nov 07;10:109
pubmed: 27872585
Exp Brain Res. 2007 Mar;177(3):336-46
pubmed: 16972073
Mov Disord. 2012 Oct;27(12):1563-6
pubmed: 23032728
Annu Rev Biomed Eng. 2019 Jun 4;21:111-143
pubmed: 31167102
Mov Disord. 2005 Dec;20(12):1577-84
pubmed: 16116612
IEEE Trans Biomed Eng. 2010 Nov;57(11):
pubmed: 20667801
IEEE Eng Med Biol Mag. 2010 May-Jun;29(3):25-36
pubmed: 20659855
Parkinsons Dis. 2015;2015:547065
pubmed: 26605103
Neuroscience. 2011 May 19;182:217-24
pubmed: 21382449
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Front Neurol. 2017 Aug 11;8:388
pubmed: 28848489
Front Neurol. 2017 Sep 01;8:431
pubmed: 28919877
Curr Biol. 2018 Mar 19;28(6):884-901.e3
pubmed: 29526593
Lancet Neurol. 2009 Dec;8(12):1128-39
pubmed: 19909911
NPJ Digit Med. 2020 Jan 17;3:6
pubmed: 31970291
Mov Disord. 2018 Jan;33(1):10-20
pubmed: 28960543
PLoS One. 2017 Oct 11;12(10):e0183989
pubmed: 29020012
Hum Mov Sci. 2010 Dec;29(6):964-76
pubmed: 20655121
Clin Biomech (Bristol, Avon). 2013 Jan;28(1):93-7
pubmed: 23062816
J Exp Biol. 2010 Dec 1;213(Pt 23):3945-52
pubmed: 21075935
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a009282
pubmed: 22675667
Prog Brain Res. 2004;143:251-61
pubmed: 14653170
Sci Rep. 2020 Apr 30;10(1):7377
pubmed: 32355166
Nat Commun. 2020 May 4;11(1):2195
pubmed: 32366867
IEEE Trans Biomed Eng. 2011 Jul;58(7):2127-35
pubmed: 21536527
Brain. 2008 Dec;131(Pt 12):3421-31
pubmed: 18930965

Auteurs

Carla Agurto (C)

IBM Research - Healthcare and Life Sciences, Yorktown Heights, Yorktown, New York, United States of America.

Stephen Heisig (S)

IBM Research - Healthcare and Life Sciences, Yorktown Heights, Yorktown, New York, United States of America.

Avner Abrami (A)

IBM Research - Healthcare and Life Sciences, Yorktown Heights, Yorktown, New York, United States of America.

Bryan K Ho (BK)

Department of Neurology, Boston, Massachusetts, United States of America.

Vittorio Caggiano (V)

IBM Research - Healthcare and Life Sciences, Yorktown Heights, Yorktown, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH